High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials.

MLA

Marcellin, Patrick, et al. “High Sustained Virologic Response Rates in Rapid Virologic Response Patients in the Large Real-World PROPHESYS Cohort Confirm Results from Randomized Clinical Trials.” Hepatology (Baltimore, Md.), vol. 56, no. 6, Dec. 2012, pp. 2039–50. EBSCOhost, https://doi.org/10.1002/hep.25892.

APA

Marcellin, P., Cheinquer, H., Curescu, M., Dusheiko, G. M., Ferenci, P., Horban, A., Jensen, D., Lengyel, G., Mangia, A., Ouzan, D., Puoti, M., Rodriguez-Torres, M., Shiffman, M. L., Schmitz, M., Tatsch, F., & Rizzetto, M. (2012). High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials. Hepatology (Baltimore, Md.), 56(6), 2039–2050. https://doi.org/10.1002/hep.25892

Chicago

Marcellin, Patrick, Hugo Cheinquer, Manuela Curescu, Geoffrey M Dusheiko, Peter Ferenci, Andrzej Horban, Donald Jensen, et al. 2012. “High Sustained Virologic Response Rates in Rapid Virologic Response Patients in the Large Real-World PROPHESYS Cohort Confirm Results from Randomized Clinical Trials.” Hepatology (Baltimore, Md.) 56 (6): 2039–50. doi:10.1002/hep.25892.